{"id":6117,"date":"2025-08-15T23:02:43","date_gmt":"2025-08-15T23:02:43","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/08\/15\/biotech-news-eli-lilly-harvard-vinay-prasad\/"},"modified":"2025-08-15T23:02:43","modified_gmt":"2025-08-15T23:02:43","slug":"biotech-news-eli-lilly-harvard-vinay-prasad","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/08\/15\/biotech-news-eli-lilly-harvard-vinay-prasad\/","title":{"rendered":"STAT+: Eli Lilly says it will hike list prices for drugs\u00a0abroad. Now what?"},"content":{"rendered":"

STAT+: Eli Lilly says it will hike list prices for drugs\u00a0abroad. Now what?
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Want to stay on top of the science and politics driving biotech today?\u00a0Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n

Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly\u2019s plan to hike list prices in Europe may play out, and more.<\/p>\n

Trump administration puts focus on march-in rights<\/h2>\n

The Trump administration recently threatened to invoke a\u00a0controversial provision of the Bayh-Dole Act to potentially seize and relicense Harvard University patents stemming from federally funded research, accusing the school of breaching disclosure and licensing rules. A letter from Commerce Secretary Howard Lutnick signaled a \u201cmarch-in\u201d review \u2014 a power never used before \u2014 which is being viewed by some as political retribution.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n STAT Staff
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: Eli Lilly says it will hike list prices for drugs\u00a0abroad. Now what? Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly\u2019s plan to hike list prices in Europe […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-6117","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6117"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6117"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6117\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}